Mitral Valve Repair With the Chord-X System: A Long Term Evaluation
Key facts
- Who runs it
- Artivion Inc.
- Where
- Edgewood, United StatesSee the siteAlso in 2 other countries, 3 sites
- Trial code
- Status
- Not yet recruiting
- People taking part
- 110 people, planned
- Started
- Jun 2026
- Expected to end
- Jun 2034
- Type of study
- Observational
- Treatments tested
- Chord-X system implant
- Record updated
- 20 February 2026
Who can take part
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 14 criteriaShow less
Who can take part
- Patient provided written Informed Consent
- Patient underwent mitral valve procedure (defined as mitral valve surgical intervention via endoscopic, mini thoracotomy, or full sternotomy approach, including mitral annuloplasty with a ring, resection of mitral valve leaflets, and replacement of mitral chordae tendineae) using the Chord-X System as clinically indicated (i.e. not off-label) by Principal Investigator at research site
- Patient's Chord-X System implant occurred no earlier than January 1, 2022
- Patient is able and willing to participate in follow-up visits for the duration of the study (i.e. through 10 years post-op)
Who cannot take part
- Patient was implanted with the Chord-X System prior to January 1, 2022
- Patient has had previous mitral valve surgery
- Patient underwent concomitant surgical procedures (except for maze procedure, PFO or LAA closure) at time of mitral repair procedure
- Patient whose mitral valve procedure was performed as part of an emergency surgery (defined as a time period from diagnosis to surgery of ≤ 48 hours)
- Patient with active or a history of endocarditis
- Patient with congenital heart disease
- Patient with an ejection fraction ≤ 50% at baseline
- Patient was implanted with the Chord-X System off-label
- Patient underwent a multi valve repair procedure
- Patient with persistent or permanent atrial fibrillation
Where in United States
Also in 2 other countries, 3 sites
- St. Elizabeth HealthcareEdgewood, United StatesContact: Cynthia MulcahyNot yet recruiting
About the trial
What the trial wants to find out
The goal of this clinical trial is to strengthen the evidence available for the Chord-X System by collecting follow-up data from patients who underwent Chord-X implant and to evaluate the long-term safety and performance data (out to 10 years). Collecting patient health information over time can help to supplement and improve the care of patients in the future.
Read full original descriptionShow less
Participants will:
Agree to the collection of their past medical history, and the details of their mitral repair surgery with the Chord-X system, including results of the follow-up examinations after implantation Visit the clinic for the routinely scheduled follow-up examination appointments
The group in the trial
- Patients who underwent mitral repair with Chord-X system beginning in January 2022
all patients who underwent a mitral valve procedure (defined as a mitral valve surgical intervention via either endoscopic, mini thoracotomy, or full sternotomy approach, including mitral annuloplasty with a ring, resection of mitral valve leaflets, and replacement of mitral chordae tendineae) using the Chord-X System, as clinically indicated, beginning in January 2022, will be approached for participation in the study.
Treatment: Chord-X system implant
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 20 February 2026